Quality Assessment of Guidelines for the Management of Helicobacter Pylori Infection_Chinese Journal of Evidence-Based Medicine

Authors：

 LICan ^1,2 , DONGShu-jie ¹ , YEZhi-kang ^1,3 ,  ZHAISuo-di ¹

1. Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China;
2. Department of Pharmacy, Xinyang Central Hospital, Xinyang 464000, China;
3. Department of Pharmacy, Beijing Chao-Yang Hospital, Beijing 100020, China;

Corresponding author：

ZHAISuo-di, Email: zhaisuodi@163.com

Keywords：

Helicobacter pylori; Guideline; AGREE Ⅱ; Systematic review

DOI：

10.7507/1672-2531.20150208

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To systematically review the quality of guidelines concerning management of helicobacter pylori (H. pylori) infection, so as to improve the guidelines of low quality and promote the clinical practice of high quality guidelines. Method Databases including PubMed, CNKI, Guidelines International Network (GIN), National Guideline Clearinghouse (NGC), National Institute for Health and Clinical Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN), American Society of Health-System Pharmacists (ASHP) and Google search engine were searched from January 2005 to April 2015 to collect guidelines concerning H. pylori management about recent ten years. The methodological quality of included guidelines was evaluated according to the AGREE Ⅱ instrument, and the difference in indications and recommended first-line therapy of H. pylori eradication among different guidelines were compared. Results A total of 13 guidelines were included. According to the AGREE Ⅱ instrument, the highest scores were for clarity and presentation 92.6% (78%-100%) and the lowest were for editorial independence 35.7% (0%-92%). The mean scores for rest domains were: scope and purpose 70.2% (39%-100%), stakeholder involvement 41.4% (22%-75%), rigor of development 41.7% (11%-82%), applicability 58.1% (35%-85%). Conclusion The quality of guidelines for management of H. pylori infection is not high. Great efforts are needed to provide reliable and high quality guidelines, especially for the domains of stakeholder involvement, rigor of development, and editorial independence.

Citation： LICan, DONGShu-jie, YEZhi-kang, ZHAISuo-di. Quality Assessment of Guidelines for the Management of Helicobacter Pylori Infection. Chinese Journal of Evidence-Based Medicine, 2015, 15(11): 1258-1264. doi: 10.7507/1672-2531.20150208 Copy

1.	Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report. Gut, 2012, 61(5):646-664.
2.	Shiota S, Murakami K, Yoshiiwa A, et al. The relationship between Helicobacter pylori infection and Alzheimer's disease in Japan. J Neurol, 2011, 258(8):1460-1463.
3.	Jeon CY, Haan MN, Cheng C, et al. Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care, 2012, 35(3):520-525.
4.	Hong SN, Lee SM, Kim JH, et al. Helicobacter pylori infection increases the risk of colorectal adenomas:cross-sectional study and meta-analysis. Dig Dis Sci, 2012, 57(8):2184-2194.
5.	Zhao YS, Wang F, Chang D, et al. Meta-analysis of different test indicators:Helicobacter pylori infection and the risk of colorectal cancer. Int J Colorectal Dis, 2008, 23(9):875-882.
6.	Zhang Y, Hoffmeister M, Weck MN, et al. Helicobacter pylori infection and colorectal cancer risk:evidence from a large population-based case-control study in Germany. Am J Epidemiol, 2012, 175(5):441-450.
7.	Inoue I, Mukoubayashi C, Yoshimura N, et al. Elevated risk of colorectal adenoma with Helicobacter pylori-related chronic gastritis:a population-based case-control study. Int J Cancer, 2011, 129(11):2704-2711.
8.	IOM (Institute of Medicine). Clinical Practice Guidelines We Can Trust. Washington, DC:The National Academies Press, 2011.
9.	Bourke B, Ceponis P, Chiba N, et al. Canadian Helicobacter Study Group Consensus Conference:Update on the approach to Helicobacter pylori infection in children and adolescents-an evidence-based evaluation. Can J Gastroenterol, 2005, 19(7):399-408.
10.	Dzieniszewski J, Jarosz M. Guidelines in the medical treatment of Helicobacter pylori infection. J Physiol Pharmacol, 2006, 57 Suppl 3: 143-154.
11.	Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol, 2007, 102(8):1808-1825.
12.	Caselli M, Zullo A, Maconi G, et al. "Cervia Ⅱ Working Group Report 2006":guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy. Dig Liver Dis, 2007, 39(8):782-789.
13.	Björn S, Aruni M, Barry M. Helicobacter pylori the latest in diagnosis and treatment. Aust Fam Physician, 2008, 37(8):608-612.
14.	Fischbach W, Malfertheiner P, Hoffmann JC, et al. Helicobacter pylori and gastroduodenal ulcer disease. Dtsch Arztebl Int, 2009, 106(49):801-808.
15.	Asaka M, Kato M, Takahashi S, et al. Guidelines for the management of Helicobacter pylori infection in Japan:2009 revised edition. Helicobacter, 2010, 15(1):1-20.
16.	Fock KM, Katelaris P, Sugano K, et al. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol, 2009, 24(10):1587-1600.
17.	Toward Optimized Practice(TOP):Guideline for the treatment of helicobacter pylori infecton adults, 2009.
18.	Hunt RH, Xiao SD, Megraud F, et al. Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. J Gastrointestin Liver Dis, 2011, 20(3):299-304.
19.	Koletzko S, Jones NL, Goodman KJ, et al. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr, 2011, 53(2):230-243.
20.	刘文忠, 谢勇, 成虹, 等. 第四次全国幽门螺杆菌感染处理共识报告. 胃肠病学, 2012, 17(10):618-625.
21.	Kim JS, Ji JS, Choi H, et al. Sequential therapy or triple therapy for Helicobacter pylori infection in Asians:systematic review and metaanalysis. Clin Res Hepatol Gastroenterol, 2014, 38(1):118-125.
22.	Gatta L, Vakil N, Leandro G, et al. Sequential therapy or triple therapy for Helicobacter pylori infection:systematic review and meta-analysis of randomized controlled trials in adults and children. Am J Gastroenterol, 2009, 104(12):3069-3079.
23.	陈尹, 胡世莲, 李幼平, 等. 全球药物干预治疗单纯性高血压指南的系统评价. 中国循证医学杂志. 2012. (10):1180-1194.
24.	陈尹, 胡世莲, 李幼平, 等. 全球药物干预治疗高血压合并其他疾病指南的系统评价. 中国循证医学杂志, 2012, 12(12):1446-1462.

1. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report. Gut, 2012, 61(5):646-664.
2. Shiota S, Murakami K, Yoshiiwa A, et al. The relationship between Helicobacter pylori infection and Alzheimer's disease in Japan. J Neurol, 2011, 258(8):1460-1463.
3. Jeon CY, Haan MN, Cheng C, et al. Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care, 2012, 35(3):520-525.
4. Hong SN, Lee SM, Kim JH, et al. Helicobacter pylori infection increases the risk of colorectal adenomas:cross-sectional study and meta-analysis. Dig Dis Sci, 2012, 57(8):2184-2194.
5. Zhao YS, Wang F, Chang D, et al. Meta-analysis of different test indicators:Helicobacter pylori infection and the risk of colorectal cancer. Int J Colorectal Dis, 2008, 23(9):875-882.
6. Zhang Y, Hoffmeister M, Weck MN, et al. Helicobacter pylori infection and colorectal cancer risk:evidence from a large population-based case-control study in Germany. Am J Epidemiol, 2012, 175(5):441-450.
7. Inoue I, Mukoubayashi C, Yoshimura N, et al. Elevated risk of colorectal adenoma with Helicobacter pylori-related chronic gastritis:a population-based case-control study. Int J Cancer, 2011, 129(11):2704-2711.
8. IOM (Institute of Medicine). Clinical Practice Guidelines We Can Trust. Washington, DC:The National Academies Press, 2011.
9. Bourke B, Ceponis P, Chiba N, et al. Canadian Helicobacter Study Group Consensus Conference:Update on the approach to Helicobacter pylori infection in children and adolescents-an evidence-based evaluation. Can J Gastroenterol, 2005, 19(7):399-408.
10. Dzieniszewski J, Jarosz M. Guidelines in the medical treatment of Helicobacter pylori infection. J Physiol Pharmacol, 2006, 57 Suppl 3: 143-154.
11. Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol, 2007, 102(8):1808-1825.
12. Caselli M, Zullo A, Maconi G, et al. "Cervia Ⅱ Working Group Report 2006":guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy. Dig Liver Dis, 2007, 39(8):782-789.
13. Björn S, Aruni M, Barry M. Helicobacter pylori the latest in diagnosis and treatment. Aust Fam Physician, 2008, 37(8):608-612.
14. Fischbach W, Malfertheiner P, Hoffmann JC, et al. Helicobacter pylori and gastroduodenal ulcer disease. Dtsch Arztebl Int, 2009, 106(49):801-808.
15. Asaka M, Kato M, Takahashi S, et al. Guidelines for the management of Helicobacter pylori infection in Japan:2009 revised edition. Helicobacter, 2010, 15(1):1-20.
16. Fock KM, Katelaris P, Sugano K, et al. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol, 2009, 24(10):1587-1600.
17. Toward Optimized Practice(TOP):Guideline for the treatment of helicobacter pylori infecton adults, 2009.
18. Hunt RH, Xiao SD, Megraud F, et al. Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. J Gastrointestin Liver Dis, 2011, 20(3):299-304.
19. Koletzko S, Jones NL, Goodman KJ, et al. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr, 2011, 53(2):230-243.
20. 刘文忠, 谢勇, 成虹, 等. 第四次全国幽门螺杆菌感染处理共识报告. 胃肠病学, 2012, 17(10):618-625.
21. Kim JS, Ji JS, Choi H, et al. Sequential therapy or triple therapy for Helicobacter pylori infection in Asians:systematic review and metaanalysis. Clin Res Hepatol Gastroenterol, 2014, 38(1):118-125.
22. Gatta L, Vakil N, Leandro G, et al. Sequential therapy or triple therapy for Helicobacter pylori infection:systematic review and meta-analysis of randomized controlled trials in adults and children. Am J Gastroenterol, 2009, 104(12):3069-3079.
23. 陈尹, 胡世莲, 李幼平, 等. 全球药物干预治疗单纯性高血压指南的系统评价. 中国循证医学杂志. 2012. (10):1180-1194.
24. 陈尹, 胡世莲, 李幼平, 等. 全球药物干预治疗高血压合并其他疾病指南的系统评价. 中国循证医学杂志, 2012, 12(12):1446-1462.

Chinese Journal of Evidence-Based Medicine

Quality Assessment of Guidelines for the Management of Helicobacter Pylori Infection

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content